These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15203137)

  • 1. Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase.
    Jain RP; Vederas JC
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3655-8. PubMed ID: 15203137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of keto-glutamine analogues as inhibitors of hepatitis A virus 3C proteinase.
    Ramtohul YK; James MN; Vederas JC
    J Org Chem; 2002 May; 67(10):3169-78. PubMed ID: 12003522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
    Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
    Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling.
    Kassem AF; Batran RZ; Abbas EMH; Elseginy SA; Shaheen MNF; Elmahdy EM
    Eur J Med Chem; 2019 Apr; 168():447-460. PubMed ID: 30844608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
    Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
    J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
    Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
    J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV.
    Bergmann EM; Cherney MM; Mckendrick J; Frormann S; Luo C; Malcolm BA; Vederas JC; James MN
    Virology; 1999 Dec; 265(1):153-63. PubMed ID: 10603326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward development of generic inhibitors against the 3C proteases of picornaviruses.
    Banerjee K; Bhat R; Rao VUB; Nain A; Rallapalli KL; Gangopadhyay S; Singh RP; Banerjee M; Jayaram B
    FEBS J; 2019 Feb; 286(4):765-787. PubMed ID: 30461192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).
    Li X; Wang Y; Wu J; Li Y; Wang Q; Xu W
    Bioorg Med Chem; 2009 Apr; 17(8):3061-71. PubMed ID: 19339187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An episulfide cation (thiiranium ring) trapped in the active site of HAV 3C proteinase inactivated by peptide-based ketone inhibitors.
    Yin J; Cherney MM; Bergmann EM; Zhang J; Huitema C; Pettersson H; Eltis LD; Vederas JC; James MN
    J Mol Biol; 2006 Aug; 361(4):673-86. PubMed ID: 16860823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).
    Li X; Wang J; Li J; Wu J; Li Y; Zhu H; Fan R; Xu W
    Bioorg Med Chem; 2009 Apr; 17(8):3053-60. PubMed ID: 19329328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.
    Zhang J; Pettersson HI; Huitema C; Niu C; Yin J; James MN; Eltis LD; Vederas JC
    J Med Chem; 2007 Apr; 50(8):1850-64. PubMed ID: 17381079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New anti-viral drugs for the treatment of the common cold.
    Maugeri C; Alisi MA; Apicella C; Cellai L; Dragone P; Fioravanzo E; Florio S; Furlotti G; Mangano G; Ombrato R; Luisi R; Pompei R; Rincicotti V; Russo V; Vitiello M; Cazzolla N
    Bioorg Med Chem; 2008 Mar; 16(6):3091-107. PubMed ID: 18248816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase.
    Malcolm BA; Lowe C; Shechosky S; McKay RT; Yang CC; Shah VJ; Simon RJ; Vederas JC; Santi DV
    Biochemistry; 1995 Jun; 34(25):8172-9. PubMed ID: 7794931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual modes of modification of hepatitis A virus 3C protease by a serine-derived beta-lactone: selective crystallization and formation of a functional catalytic triad in the active site.
    Yin J; Bergmann EM; Cherney MM; Lall MS; Jain RP; Vederas JC; James MN
    J Mol Biol; 2005 Dec; 354(4):854-71. PubMed ID: 16288920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(A) binding protein, C-terminally truncated by the hepatitis A virus proteinase 3C, inhibits viral translation.
    Zhang B; Morace G; Gauss-Müller V; Kusov Y
    Nucleic Acids Res; 2007; 35(17):5975-84. PubMed ID: 17726047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro.
    Jain RP; Pettersson HI; Zhang J; Aull KD; Fortin PD; Huitema C; Eltis LD; Parrish JC; James MN; Wishart DS; Vederas JC
    J Med Chem; 2004 Dec; 47(25):6113-6. PubMed ID: 15566280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of anti-coxsackievirus agents targeting 3C protease.
    Kim BK; Kim JH; Kim NR; Lee WG; Lee SD; Yun SH; Jeon ES; Kim YC
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6952-6. PubMed ID: 23062551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and testing of azaglutamine derivatives as inhibitors of hepatitis A virus (HAV) 3C proteinase.
    Huang Y; Malcolm BA; Vederas JC
    Bioorg Med Chem; 1999 Apr; 7(4):607-19. PubMed ID: 10353640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Mulberrofuran as a potent inhibitor of hepatitis A virus 3C
    Sureshan M; Brintha S; Jothi A
    Mol Divers; 2024 Jun; 28(3):1609-1628. PubMed ID: 37386350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.